TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Vitalis Pharma AS
Closing information (x1000 NOK)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
103,832
|
99,054
|
100,019 |
| Financial expenses |
320
|
388
|
526 |
| Earnings before taxes |
27,120
|
17,173
|
21,240 |
| Total assets |
42,487
|
56,905
|
48,286 |
| Current assets |
8,390
|
18,939
|
16,939 |
| Current liabilities |
7,610
|
31,016
|
30,907 |
| Equity capital |
516
|
2,553
|
378 |
| - share capital |
300
|
300
|
300 |
| Employees (average) | 4 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
1.2%
|
4.5%
|
0.8% |
| Turnover per employee | 25,958 | ||
| Profit as a percentage of turnover |
26.1%
|
17.3%
|
21.2% |
| Return on assets (ROA) |
64.6%
|
30.9%
|
45.1% |
| Current ratio |
110.2%
|
61.1%
|
54.8% |
| Return on equity (ROE) |
5255.8%
|
672.7%
|
5619.0% |
| Change turnover |
4,778
|
-965
|
47,346 |
| Change turnover % |
5%
|
-1%
|
90% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.